Key result
Current guideline-recommended starting doses of adenosine for supraventricular tachycardia are effective in only 9% of infants and children.
Why the study?
Are guideline-recommended starting doses of adenosine effective in infants and children with supraventricular tachycardia?
Population
Infants and children with supraventricular tachycardia
Design
Cohort
Authors
Loading...
Guideline starting doses may be inadequate for most pediatric SVT; hypothesis-generating for dose optimization trials before any practice change.
Are guideline-recommended starting doses of adenosine effective in infants and children with supraventricular tachycardia?
Current guideline-recommended starting doses of adenosine for supraventricular tachycardia are largely ineffective in pediatric patients.
Jonathan Dixon (2005) studied this question. Current guideline-recommended starting doses of adenosine for supraventricular tachycardia are effective in only 9% of infants and children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: